查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916933

噬菌体DNA分离试剂盒市场：依萃取方法、试剂盒规格、应用和最终用户划分－2026-2032年全球预测

Phage DNA Isolation Kit Market by Extraction Method, Kit Format, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年噬菌体 DNA 分离试剂盒市值为 1.6901 亿美元，预计到 2026 年将成长至 1.9226 亿美元，年复合成长率为 12.43%，到 2032 年将达到 3.8386 亿美元。

关键市场统计数据
基准年 2025 1.6901亿美元
预计年份：2026年 1.9226亿美元
预测年份 2032 3.8386亿美元
复合年增长率 (%) 12.43%

简洁而有力地介绍了噬菌体 DNA 分离试剂盒在诊断、环境检测和研究中的策略重要性。

噬菌体相关应用的兴起，使得可靠的噬菌体DNA分离工具在诊断、环境检测和实验室中的重要性日益凸显。本执行摘要全面概述了影响噬菌体DNA分离试剂盒普及的技术、监管和商业性趋势，并重点阐述了其对参与检测方法开发、监测项目以及治疗药物研发的相关人员的实际意义。

技术融合、不断演进的工作流程以及以噬菌体为中心的应用日益增多，正在重塑供应商的优先事项和实验室的筹资策略。

噬菌体DNA分离领域正经历变革性的转变，这主要得益于技术创新、实验室工作流程的演进以及各领域对高精度核酸输入的需求。自动化磁珠化学和新一代耗材技术的进步实现了高通量和更少的操作时间，从而促进了临床诊断实验室对结果可重复性和监管可追溯性的要求。同时，手动硅胶膜分离技术的改进仍然具有重要意义，它为学术机构和小规模受託研究机构提供了一种经济高效且易于使用的解决方案。

评估 2025 年美国对噬菌体 DNA 分离试剂盒的采购和製造征收关税对营运和供应链的累积影响。

美国2025年实施的关税对与噬菌体DNA分离试剂盒相关的供应链经济、采购决策和供应商策略产生了累积影响。关税带来的成本压力增加，促使企业更加重视区域采购和关键试剂的在地化生产，从而重新评估製造地和进口依赖程度。在评估采购韧性时，许多企业优先考虑与拥有地域分散的製造地和完善库存管理的供应商合作，以降低其受国际关税波动的影响。

策略性細項分析揭示了应用需求、最终用户优先顺序、萃取技术和试剂盒形式如何影响采购和开发选择。

深入的細項分析揭示了应用、最终用户、萃取方法和试剂盒形式如何影响噬菌体DNA分离领域的产品需求和购买行为。按应用评估，临床诊断优先考虑感染疾病诊断和病原体检测工作流程，这些流程需要严格的检验、完整的监管链文件以及与高通量自动化系统的整合。环境监测应用，例如食品安全、土壤分析和水质检测，重视基质适应性和抗抑制剂化学，以确保噬菌体DNA在异质样本中保持高品质。研究型应用，例如基因组学、噬菌体疗法开发和疫苗开发，重视柔软性、通讯协定透明度以及与下游定序和分析平台的兼容性。

关键区域洞察：阐述美洲、欧洲、中东和非洲以及亚太市场在采购因素和供应商策略上的差异

区域趋势正清楚地影响着美洲、欧洲、中东和非洲以及亚太地区噬菌体DNA分离技术的应用模式和供应商策略。在美洲，先进的临床实验室和充满活力的学术研究生态系统推动了市场需求，这些机构优先考虑自动化、检验的工作流程以及与定序平台的整合。某些市场的供应链考量和监管政策的明确性也促使製造商维护强大的本地分销网络和服务支持，以实现快速响应。

噬菌体DNA分离市场的竞争动态、供应商差异化策略，以及供应商如何赢得信任并扩大其在不同客户群中的规模。

噬菌体DNA分离领域的竞争格局呈现出均衡的态势，既有成熟的生命科学供应商，也有专注于特定领域的专业厂商，还有灵活敏捷、致力于化学创新和工作流程整合的新兴企业。成熟的供应商凭藉其丰富的产品系列、全球分销网络以及跨产品协同效应，提供满足高通量临床和生物製药客户需求的端到端解决方案。这些企业往往强调检验的通讯协定、完善的法规支援以及确保相容性和持续耗材需求的仪器生态系统。

针对试剂盒供应商和实验室负责人的实用策略建议：提高韧性、扩大应用范围并加速噬菌体DNA分离工作流程的整合

产业领导者应优先采取以下切实可行的步骤，以巩固市场地位、降低营运风险并加速噬菌体DNA分离解决方案的普及应用。首先，投资于模组化产品系列，使客户能够在不改变核心化学原理的情况下，从手动工作流程扩展到自动化工作流程，从而降低转换成本并支援长期合作关係的建立。其次，扩大检验研究范围，以证明该解决方案在临床检体（拭子）、污水、食品样本和土壤等关键基质中具有一致的性能，从而增强诊断检查室和环境检测机构对检测方法可靠性的信心。

为了确保研究结果的可靠性，我们采用严格的混合方法调查方法，结合相关人员访谈、技术评估和三角验证的二次分析。

本分析的调查方法结合了定性和定量技术，旨在全面、深入地了解噬菌体DNA分离的现状。关键数据来源包括对来自学术研究机构、生物製药开发团队、临床诊断检查室和受託研究机构（CRO）的相关人员进行深度访谈，以获取有关工作流程限制、性能预期和采购重点的第一手资讯。此外，还对提取化学技术和试剂盒形式进行了技术评估，重点关注DNA产量、抑制剂抗性、操作时间、通量相容性和文件品质等性能指标。

简明扼要的结论整合了技术、商业性和策略的关键要点，旨在指导噬菌体DNA分离领域的投资、采购和产品开发决策。

本执行摘要概述了噬菌体DNA分离技术领域的关键发现及其对相关相关人员的策略意义。自动化多粒子珠系统和优化的二氧化硅膜耗材的进步，透过提供更高通量、更佳重复性和适用于多种样品基质的解决方案，正在重新定义实验室的预期。从学术机构到生物製药公司再到临床诊断检查室等终端用户，都已展现出明确的优先事项，这些事项会影响试剂盒的选择和伙伴关係重点，凸显了客製化价值提案的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依萃取方法分類的噬菌体DNA分离试剂盒市场

  • 磁珠
    • 自动化磁珠检测
    • 手动磁珠
  • 二氧化硅膜
    • 版式
    • 旋转柱格式

9. 噬菌体DNA分离试剂盒市场（依试剂盒类型划分）

  • 汽车套件
  • 手册套件

第十章 噬菌体DNA分离试剂盒市场（依应用领域划分）

  • 临床诊断
    • 感染疾病诊断
    • 病原体检测
  • 环境监测
    • 食品安全
    • 土壤分析
    • 水质检测
  • 研究
    • 基因组研究
    • 噬菌体疗法的发展
    • 疫苗研发

第十一章 噬菌体DNA分离试剂盒市场（依最终用户划分）

  • 学术研究机构
  • 生物製药公司
  • 临床检查室
  • CRO（受託研究机构）

第十二章 噬菌体DNA分离试剂盒市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 噬菌体DNA分离试剂盒市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国噬菌体DNA分离试剂盒市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章美国噬菌体DNA分离试剂盒市场

第十六章：中国噬菌体DNA分离试剂盒市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Bio-Rad Laboratories, Inc.
  • BioCat GmbH
  • Geneflow Ltd.
  • Hangzhou Bigfish Bio-tech Co., Ltd.
  • LubioScience AG
  • Merck KGaA
  • MP Biomedicals, LLC
  • Norgen Biotek Corp.
  • Omega Bio-tek, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Thomas Scientific, LLC
  • Zymo Research Corporation
Product Code: MRR-AE420CB15403

The Phage DNA Isolation Kit Market was valued at USD 169.01 million in 2025 and is projected to grow to USD 192.26 million in 2026, with a CAGR of 12.43%, reaching USD 383.86 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 169.01 million
Estimated Year [2026] USD 192.26 million
Forecast Year [2032] USD 383.86 million
CAGR (%) 12.43%

A concise, high-impact introduction that frames the strategic importance of phage DNA isolation kits across diagnostics, environmental testing, and research

The emergence of bacteriophage-focused applications has elevated the importance of reliable phage DNA isolation tools across diagnostics, environmental testing, and research laboratories. This executive summary presents an integrative view of the technological, regulatory, and commercial dynamics shaping adoption of phage DNA isolation kits, emphasizing practical implications for stakeholders engaged in assay development, surveillance programs, and therapeutic R&D.

Phage DNA isolation is increasingly recognized as a critical upstream process that directly influences downstream sequencing accuracy, qPCR sensitivity, and the quality of whole-genome assemblies. As laboratories prioritize throughput, reproducibility, and contamination control, the choice of extraction method and kit format becomes a strategic decision. Automated magnetic bead workflows offer consistency and scalability for high-volume operations, while manual spin-column or plate-based approaches continue to serve low-throughput and resource-constrained settings. These operational trade-offs have meaningful consequences for lab workflows, personnel training, and capital expenditures.

In addition to technical considerations, supply chain resilience, regulatory clarity for diagnostic use, and partnerships between kit suppliers and service laboratories are shaping procurement patterns. The following sections unpack transformative shifts, tariff-related impacts from U.S. policy changes in 2025, segmentation-driven insights, regional dynamics, competitive behaviors, actionable recommendations, and the research methodology that underpins these conclusions.

How technological convergence, workflow evolution, and rising phage-centric applications are reshaping supplier priorities and laboratory procurement strategies

The landscape for phage DNA isolation is undergoing transformative shifts driven by convergence of technological innovation, evolving laboratory workflows, and cross-sector demand for high-fidelity nucleic acid inputs. Advances in automated magnetic bead chemistry and next-generation consumable formats are enabling higher throughput with reduced hands-on time, which in turn encourages adoption in clinical diagnostic laboratories that require robust reproducibility and regulatory traceability. Concurrently, improvements in manual silica membrane formats maintain relevance by offering cost-effective, accessible solutions for academic settings and smaller contract research operations.

Moreover, the growing prominence of phage-based therapies and genomic surveillance has strengthened demand for extraction methods that preserve DNA integrity across diverse sample matrices, including environmental and clinical specimens. This has catalyzed vendor investments in extraction chemistries optimized for low-abundance phage genomes and in protocols tailored for complex matrices such as soil and wastewater. As a result, strategic partnerships between kit providers and sequencing or diagnostic service labs are becoming more common, enabling rapid validation pathways and application-specific kit adaptations.

Regulatory expectations and quality management practices are also pushing suppliers toward more transparent documentation, lot-to-lot consistency, and compatibility statements for downstream assays. These shifts collectively favor versatile platforms that balance automation, reliability, and adaptability, while also highlighting the need for vendors to demonstrate operational value beyond mere kit performance.

Assessing the cumulative operational and supply chain consequences of United States tariff measures in 2025 for phage DNA isolation kit procurement and manufacturing

U.S. tariff actions implemented in 2025 have exerted a cumulative influence on supply chain economics, sourcing decisions, and vendor strategies relevant to phage DNA isolation kits. Tariff-induced cost pressures amplified attention on regional sourcing and the localization of critical reagent production, prompting several suppliers to reassess manufacturing footprints and import dependencies. As organizations evaluated procurement resilience, many prioritized partnerships with suppliers offering diversified geographic manufacturing or robust inventory management to mitigate exposure to international tariff volatility.

In practical terms, increased landed costs for certain imported consumables incentivized laboratories and procurement teams to explore domestic alternatives or to negotiate longer-term supply agreements that included price stabilization clauses. For kit manufacturers, tariffs prompted accelerated investments in regional manufacturing capacity and in supply chain transparency to assure customers of continuity. These adjustments were particularly pronounced for high-volume clinical diagnostic laboratories and contract research organizations that depend on predictable supply schedules and cost structures.

Beyond immediate cost implications, the tariff environment stimulated broader strategic change: vendors intensified efforts to qualify local distributors, to optimize logistics and customs handling, and to redesign packaging and kit compositions to reduce cross-border tariff sensitivity. Transitioning toward localized reagent sourcing also dovetailed with quality and regulatory priorities, since regional supply chains can simplify compliance with national procurement rules and streamline documentation for clinical use. Collectively, these dynamics are fostering a more resilient, regionally attuned supply ecosystem for phage DNA isolation products.

Strategic segmentation insights revealing how application needs, end-user priorities, extraction technologies, and kit formats dictate procurement and development choices

Insightful segmentation analysis reveals how application, end user, extraction method, and kit format influence product requirements and purchasing behavior across the phage DNA isolation space. When evaluated by application, clinical diagnostics demands prioritize infectious disease diagnosis and pathogen detection workflows that require rigorous validation, chain-of-custody documentation, and integration with high-throughput automated systems. Environmental monitoring applications such as food safety, soil analysis, and water testing place a premium on matrix adaptability and inhibitors-tolerant chemistries that preserve phage DNA quality across heterogeneous samples. Research-oriented applications including genomic research, phage therapy development, and vaccine development value flexibility, protocol transparency, and compatibility with downstream sequencing and analytical platforms.

Considering end-user segments, academic research institutions often balance cost-effectiveness with methodological openness, favoring manual kits and plate formats that support iterative method development. Biopharmaceutical companies require scalable, GMP-aligned processes that integrate with internal quality systems and support regulatory dossiers for therapeutic programs. Clinical diagnostic laboratories prioritize validated automated solutions and reproducibility benchmarks, while contract research organizations emphasize turnaround time, assay robustness, and vendor responsiveness for large-scale studies.

Across extraction methods, magnetic bead technologies, available in automated and manual configurations, are increasingly chosen for their scalability and reduced contamination risk, whereas silica membrane options, offered in plate and spin column formats, remain relevant for laboratories that require straightforward, low-equipment workflows. Finally, the dichotomy of automated kits versus manual kits captures the trade-off between throughput and cost, with automation favored where volume, traceability, and reduced operator variability are imperative, and manual formats continuing to serve resource-limited or development-focused environments.

Key regional insights describing how procurement drivers and supplier strategies differ across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics are shaping adoption patterns and vendor strategies for phage DNA isolation technologies in discernible ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, demand is driven by a mix of advanced clinical laboratories and vibrant academic research ecosystems that prioritize automation, validated workflows, and integration with sequencing platforms. Supply chain considerations and regulatory clarity in certain markets also motivate manufacturers to maintain strong local distribution networks and service support for rapid turnaround.

In Europe, Middle East & Africa, diverse regulation and heterogeneous public health infrastructure influence kit choice, with significant interest in adaptable solutions that can meet both centralized clinical laboratory standards and decentralized environmental monitoring needs. Vendors operating in this region often emphasize comprehensive technical support, multilingual documentation, and validation data that align with varying national requirements. Meanwhile, in the Asia-Pacific region, rapid expansion of research capacity, growing biopharmaceutical investment, and emerging clinical diagnostic networks are fueling demand for both automated magnetic bead systems and cost-conscious manual silica membrane options. Supplier strategies here frequently include strategic partnerships, localized manufacturing, and tailored pricing models to address varied market maturity levels.

Across all regions, priorities such as supply reliability, local technical support, and clear compatibility with downstream assays are central to procurement decisions, with regional nuances informing how vendors position product portfolios and after-sales services.

Competitive dynamics and supplier differentiation strategies that define the phage DNA isolation market, highlighting how vendors secure trust and scale with diverse customer segments

Competitive behavior in the phage DNA isolation arena reflects a balanced mix of established life science suppliers, specialized niche vendors, and agile new entrants that focus on chemistry innovation or workflow integration. Established suppliers leverage broad portfolios, global distribution networks, and cross-product synergies to offer end-to-end solutions that appeal to high-throughput clinical and biopharma customers. These players often emphasize validated protocols, regulatory support, and instrument ecosystems that lock in compatibility and recurring consumable demand.

Specialized vendors differentiate through targeted extraction chemistries optimized for phage genome recovery from challenging matrices or by developing consumable formats that reduce hands-on time and contamination risk for sequencing and qPCR applications. New entrants and smaller innovators frequently concentrate on a single component of the workflow-such as magnetic bead formulations or inhibitor removal modules-enabling focused performance advantages that can be rapidly validated with collaborative research partners.

Service-oriented firms, including contract research and contract manufacturing organizations, play a pivotal role by integrating kit suppliers into end-user workflows, offering validation services, and accelerating time-to-data for customers. Across this competitive spectrum, successful vendors prioritize technical documentation, robust quality systems, and responsive customer support to build trust with clinical laboratories, biopharma developers, and academic research teams alike.

Actionable strategic recommendations for kit suppliers and laboratory leaders to strengthen resilience, expand adoption, and accelerate integration of phage DNA isolation workflows

Industry leaders should prioritize a set of pragmatic actions to strengthen market position, reduce operational risk, and accelerate adoption of phage DNA isolation solutions. First, invest in modular product portfolios that allow customers to scale from manual to automated workflows without changing core chemistries, thereby lowering switching costs and supporting long-term relationships. Second, expand validation studies that demonstrate consistent performance across key matrices-clinical swabs, wastewater, food samples, and soil-in order to reassure diagnostic labs and environmental testing providers about assay robustness.

Third, focus on supply chain resilience by qualifying multiple regional suppliers for critical reagents and by enhancing inventory transparency with customers. This strategic step mitigates the impact of cross-border trade disruptions and tariff shifts while supporting rapid order fulfillment. Fourth, deepen partnerships with sequencing providers, clinical laboratories, and contract research organizations to co-develop application-specific kits and to generate real-world validation data that shortens customer evaluation cycles. Fifth, enhance customer support capabilities, including training modules, protocol optimization services, and technical exercises that reduce adoption friction for laboratory personnel.

Finally, align product roadmaps with regulatory expectations by documenting manufacturing practices, lot-to-lot consistency, and traceability, which are particularly important for diagnostic and therapeutic development customers. Taken together, these actions will help vendors convert technological advantages into sustainable, customer-centered growth.

A rigorous, mixed-methods research methodology combining stakeholder interviews, technical assessment, and triangulated secondary analysis to ensure credible insights

The research methodology underpinning this analysis combined qualitative and quantitative techniques to produce a robust, multi-dimensional view of the phage DNA isolation landscape. Primary inputs included in-depth interviews with stakeholders across academic research institutions, biopharmaceutical development teams, clinical diagnostic laboratories, and contract research organizations to capture firsthand perspectives on workflow constraints, performance expectations, and procurement priorities. These conversations were complemented by technical assessments of extraction chemistries and kit formats, focusing on performance attributes such as DNA yield, inhibitor tolerance, hands-on time, throughput compatibility, and documentation quality.

Secondary research involved a systematic review of peer-reviewed literature, technical white papers, regulatory guidances, and publicly available product documentation to validate technical claims and to understand prevailing best practices for phage DNA handling. Competitive intelligence captured product differentiation, distribution strategies, and investment patterns without relying on proprietary datasets. Cross-validation of findings was achieved through triangulation across interview insights, technical data, and publicly disclosed vendor information.

The analytical approach emphasized segmentation by application, end user, extraction method, and kit format to ensure nuanced recommendations. Sensitivity checks addressed supply chain variables, such as regional manufacturing capacities and trade policy shifts, to identify strategic levers that suppliers and laboratory customers can use to improve resilience. Throughout, methodological rigor was maintained by documenting assumptions, interview protocols, and criteria for assessing technical performance and vendor reliability.

A succinct conclusion synthesizing technical, commercial, and strategic takeaways to guide investment, procurement, and product development decisions in the phage DNA isolation domain

This executive summary consolidates the central findings and strategic implications for stakeholders engaged with phage DNA isolation technologies. Advances in automated magnetic bead systems and optimized silica membrane consumables are redefining laboratory expectations by offering pathways to higher throughput, improved reproducibility, and adaptable solutions for diverse sample matrices. End users-ranging from academic institutions to biopharmaceutical companies and clinical diagnostic laboratories-exhibit distinct priorities that influence kit selection and partnership preferences, underscoring the importance of tailored value propositions.

Regional considerations and recent trade policy developments have prompted suppliers to increase supply chain transparency, pursue regional manufacturing options, and enhance localized technical support. Competitive dynamics reward vendors that combine chemistry performance with operational services such as validation support and training, while specialized innovators can capture niche opportunities by addressing matrix-specific extraction challenges. For laboratory leaders and procurement teams, the core takeaway is the need to evaluate extraction solutions not only on immediate performance metrics but also on factors such as scalability, regulatory alignment, and supply continuity.

Taken together, these insights provide a strategic lens for aligning product development, commercial execution, and customer engagement to accelerate adoption and to deliver reliable nucleic acid inputs for downstream phage genomic and diagnostic workflows.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Phage DNA Isolation Kit Market, by Extraction Method

  • 8.1. Magnetic Bead
    • 8.1.1. Automated Magnetic Bead
    • 8.1.2. Manual Magnetic Bead
  • 8.2. Silica Membrane
    • 8.2.1. Plate Format
    • 8.2.2. Spin Column Format

9. Phage DNA Isolation Kit Market, by Kit Format

  • 9.1. Automated Kits
  • 9.2. Manual Kits

10. Phage DNA Isolation Kit Market, by Application

  • 10.1. Clinical Diagnostics
    • 10.1.1. Infectious Disease Diagnosis
    • 10.1.2. Pathogen Detection
  • 10.2. Environmental Monitoring
    • 10.2.1. Food Safety
    • 10.2.2. Soil Analysis
    • 10.2.3. Water Testing
  • 10.3. Research
    • 10.3.1. Genomic Research
    • 10.3.2. Phage Therapy Development
    • 10.3.3. Vaccine Development

11. Phage DNA Isolation Kit Market, by End User

  • 11.1. Academic Research Institutions
  • 11.2. Biopharmaceutical Companies
  • 11.3. Clinical Diagnostic Laboratories
  • 11.4. Contract Research Organizations

12. Phage DNA Isolation Kit Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Phage DNA Isolation Kit Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Phage DNA Isolation Kit Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Phage DNA Isolation Kit Market

16. China Phage DNA Isolation Kit Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bio-Rad Laboratories, Inc.
  • 17.6. BioCat GmbH
  • 17.7. Geneflow Ltd.
  • 17.8. Hangzhou Bigfish Bio-tech Co., Ltd.
  • 17.9. LubioScience AG
  • 17.10. Merck KGaA
  • 17.11. MP Biomedicals, LLC
  • 17.12. Norgen Biotek Corp.
  • 17.13. Omega Bio-tek, Inc.
  • 17.14. Promega Corporation
  • 17.15. QIAGEN N.V.
  • 17.16. Takara Bio Inc.
  • 17.17. Thermo Fisher Scientific Inc.
  • 17.18. Thomas Scientific, LLC
  • 17.19. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHAGE DNA ISOLATION KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHAGE DNA ISOLATION KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED MAGNETIC BEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED MAGNETIC BEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED MAGNETIC BEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL MAGNETIC BEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL MAGNETIC BEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL MAGNETIC BEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PLATE FORMAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PLATE FORMAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PLATE FORMAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SPIN COLUMN FORMAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SPIN COLUMN FORMAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SPIN COLUMN FORMAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PATHOGEN DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PATHOGEN DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SOIL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SOIL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY SOIL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY WATER TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GENOMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GENOMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PHAGE THERAPY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PHAGE THERAPY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY PHAGE THERAPY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 210. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 211. G7 PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 219. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 220. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL PHAGE DNA ISOLATION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY MAGNETIC BEAD, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY SILICA MEMBRANE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA PHAGE DNA ISOLATION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)